Max Robotics — Global Service Robot Directory + US Certification

About

Daniel H. Dunn is a pioneering surgeon whose research has fundamentally advanced the field of minimally invasive esophageal cancer surgery. His primary focus is on the development and refinement of robot-assisted transhiatal esophagectomy (RATE), a technically demanding procedure that offers significant advantages over traditional open surgery. Dr. Dunn’s major contributions include demonstrating that RATE can achieve clear surgical margins while reducing morbidity and shortening hospital stays. His landmark 2012 paper, “Robot-assisted transhiatal esophagectomy: a 3-year single-center experience,” has been cited over 80 times, establishing a foundational protocol for robotic approaches. He also identified and addressed a critical postoperative complication—incarcerated hiatal hernia—in a 2010 study (53 citations), proposing preventive strategies that have become standard practice. In his largest series, published in 2017, Dr. Dunn reported operative and survival outcomes from 100 consecutive RATE cases, providing robust evidence for the procedure’s safety and oncologic efficacy. Through this body of work, Dr. Dunn has not only expanded the technical possibilities of robotic surgery but also improved long-term outcomes for esophageal cancer patients, cementing his role as a leader in surgical innovation.